Abstract 4-Hydroxybenzoate oligoprenyl transferase from E. coli (ubiA-prenyl transferase) is a crucial enzyme for ubiquinone biosynthesis. It catalyzes the formation of 3-oligoprenyl-4-hydroxybenzoates like geranyl hydroxybenzoate (GHB, 23) from geranyl pyrophosphate (GPP, 22). Several analogues and mimics of geranyl pyrophosphate have been prepared for an examination of their ability to inhibit the enzyme. 7,11-Dimethyl-3-oxododeca-6,10-dienoic acid (2), 3-hydroxy-7,11-dimethyldodeca-6,10-dienoic acid (3), 2-hydroxy-4,8-dimethyl-3,7-nonadienylphosphonic acid (4), and tripotassium [[(4E)-5,9-dimethyldeca-4,8-dienyl]phosphinato](difluoro)methylphosphonate (5) were synthesized from geraniol. ω-2,ω-1-Dihydroxylated farnesyl diphosphate 6 was prepared from trans,trans-farnesol. All compounds were tested for enzyme inhibition in a competitive assay with natural substrate. The effect of these compounds on ubiA-prenyltransferase activity varied substantially, ranging from almost full inhibition to, surprisingly, enhanced enzymatic activity at low concentrations by some compounds. A special, EDTAmodifyable magnesium effect is discussed as potential reason.
Introduction
In vivo, the enzyme transfers diphosphorylated acyclic oligoprenyl moieties (diphosphorylated terpene alcohols) to the meta-position of 4-hydroxybenzoic acid (PHB). Possible candidates for mimics of geranyl diphosphate should fulfill three requirements: they should show affinity to a prenyl diphosphate synthase or transferase; they should be stable under study conditions, especially against hydrolysis; and they should be easy to synthesize. With these requirements in mind, we approached two different classes of candidates for our approach. The first class consists of non-hydrolysable diphosphate analogues with phosphorus-based acidic moieties, the second one of mimics where all phosphates are replaced by non-phosphorus (acidic) moieties.
A natural example of the latter group is chaetomellic acid (1, Figure 1 ), which was isolated from the coelomycete Chaetomella acutiseta. It inhibits farnesyl-protein-transferase at IC50-values in the nanomolar range. 7 Chaetomellic acid is a competitor to farnesyl pyrophosphate (FPP), and does not contain any phosphate moiety. We were interested in the synthesis of the similar β-keto acid 2 and β-hydroxy acid 3 which might act as competitive inhibitors of ubiA-p-hydroxybenzoate oligoprenyl transferase ( Figure 2) .
As examples of the first class, several non-hydrolysable allylic diphosphate mimics are known from the literature. These include phosphonophosphates, 8 phosphonophosphinates, 9 and diphosphonates, 10 where the methylene group replaces the oxygen between phosphorus and hydroxy-3,7,11-trimethyldodeca-2,6-dienyl diphosphate (6), i.e. oxidized FPP, was included.
Although it is a hydrolysable substrate in principle, we knew from earlier experiments that it is accepted poorly by ubiA-transferase and thus, it may act as an inhibitor. In this report, we present the synthesis of these compounds, along with a study of their impact on the magnesium depended activity of aromatic ubiA-oligoprenyl transferase of E. coli. 
Results and Discussion

Syntheses
The synthesis of the β-keto acid 2 and β-hydroxy acid 3 is shown in Scheme 2. Methyl acetoacetate was selectively alkylated at position 4 with geranyl bromide. Treatment of the resulting β-keto ester 7 with LiOH in THF/H 2 O gave the desired alkylated β-carboxylic acid 2. Reduction of ketone 7 with NaBH 4 in MeOH produced β-hydroxy ester 8, which upon hydrolysis with LiOH in THF/H 2 O afforded the racemic β-hydroxy acid 3. The synthesis of the geranyl-based phosphonate 4 (Scheme 3) started with the Doering oxidation of geraniol to geranial (9) , which was reacted with dimethyl methylphosphonate anion to give racemic 10. This methyl phosphonic ester was cleaved with trimethylsilyl bromide in the presence of 2,4,6-collidine as acid scavenger to afford the free hydroxyphosphonic acid 4. 14, 15 An attempt to oxidize β-hydroxy phosphonate 3 to the β-keto phosphonate by Doering oxidation failed. Scheme 3. Synthesis of geranyl-based β-hydroxy phosphonic acid 4.
The synthetic route to phosphonate 5 (Scheme 4), a hydrolytically stable analog of diphosphates, was identical to one known for a farnesyl derivative. 14 The difluoromethylene link is a better oxygen mimic than methylene. Thus, geraniol was subjected to a standard C 2 -homologation to form ester 11, followed by ester reduction and conversion of the resulting alcohol into bromide 12. The Arbuzov reaction 16 of 12 with excess of triethyl phosphate delivered in high yield diester 13, which by base-induced hydrolysis was converted into the mono acid. Subsequent DMF-catalyzed reaction with oxalyl chloride in benzene at room temperature afforded ethyl phosphonochloridoate 14. Treatment of the intermediate mono phosphonate with excess N,N-dimethylaminotrimethylsilane in dichloromethane prior to acid chloride formation resulted in a faster reaction and a cleaner transformation into ethyl phosphonochloridoate 14.
14,17
Subsequent C-P coupling reaction was performed by dropwise addition of a THF solution of 14 to a solution of the anion 15 at -78 °C. The anion 15 was formed by the reaction of LDA with diethyl difluoromethylphosphonate. 18 The resulting diester 16 was cleaved with TMS-I in the presence of 2,4,6-collidine as acid scavenger 14 to produce the desired product 5. 
Scheme 5. Synthesis of (E,E)-10,11-dihydroxyfarnesyl diphosphate 6.
The synthesis of (E,E)-10,11-dihydroxyfarnesyl diphosphate started from all-trans farnesol (Scheme 5), protected as acetate 17. For selective epoxidation of the 10,11-double bond we followed a method developed by van Tamelen et al. 19 Farnesyl acetate was treated with NBS in aqueous tert-butyl alcohol 20 or aqueous 1,2-dimethoxyethane 21 to give the desired bromohydrin farnesol 20 was converted into chloride 21, which was finally transformed into (E,E)-10,11-dihydroxyfarnesyl diphosphate according to Davisson et al. 
UbiA-Transferase inhibition
The compounds described above were tested for their ability to inhibit ubiA-transferase using a membrane fraction of a cell disruption of the E. coli K12 strain pALMU3. 24 Compounds were assayed in competition to 1 mM geranyl diphosphate (GPP) at concentrations ranging up to 1 mM (Scheme 6). These results, expressed as the geranyl hydroxylbenzoate (GHB) formation in the presence of the compound divided by the GHB formation in the absence of the compound (i.e. relative conversions) are shown in Figures 3 and 4 . Only β-hydroxy acid 3 and β-keto acid 2 showed significant inhibitory activity regarding the conversion of geranyl diphosphate ( Figure 3) . 25 Their IC50 values are 0.36 and 0.58 mM, respectively. At 1 mM concentration, β-hydroxy carboxylate 3 showed almost complete inhibition of ubiA-transferase activity. β-Hydroxy phosphonate (from 4, remaining activity: 90% at 1 mM, data not shown) and difluoro phosphinophosphonate 5 did not show significant inhibitory activity. Although these molecules are structurally more related to the natural substrate than the carboxylic acids, the lower binding affinities have been attributed to differences in the pK a of the phosphate versus the phosphonate groups. 26 Difluoromethylene analogues more closely match the pK a , but the fluorine atoms introduce steric interactions and other properties not found in the natural diphosphate substrates. 26 Another reason for the low activity of 4 and 5 might be the structural difference compared to the natural substrates because in 4 the distance of the diphosphate mimicking moiety to the first double bond is shorter, in 5 it is longer by one atom than in natural oligoprenyl diphosphates.
(E,E)-10,11-Dihydroxyfarnesyl diphosphate 6 is only very poorly accepted as substrate, although sterically it must be acceptable to the enzyme as has been shown by us before in a substrate model.
12 Surprisingly, under standard conditions as described above, its inhibitory effect is very weak too. The results for β-hydroxy carboxylate 3 (■, □) and for phosphinato(difluoro)-methylphosphonate 5 (▲, ) are shown with squares and triangles, respectively. Empty data points □, : the membrane fraction contained 0.67 mg protein/mL; filled data points ■, ▲: the membrane fraction contained 2.68 mg protein/mL. For standard assay conditions see Experimental Section.
From our earlier experiments we know that even a small reduction in the concentration of the magnesium ions results in an increase of product formation (through enhanced enzyme stability).
6b, 27 Although elevated concentrations of magnesium ions ensure a high initial rate of the enzymatic reaction, they cause the enzyme denaturation much faster then in experiments where the MgCl 2 concentration is reduced. Thus, high salt concentration ultimately results in lower turnover. We suppose that the dual role played by MgCl 2 is particularly responsible for the increased enzymatic activity observed with small amounts of inhibitor. Because the tested inhibitors are diphosphate mimics, they are also able to form complexes with Mg 2+ -ions. Due to this complexation, especially with phosphinato(difluoro)methylphosphonate 5, an activity increase up to 47% was observed. In order to prove this hypothesis, an alternative Mg 2+ -scavenger, which should not have any inhibitory activity, was applied to the system. Indeed, experiments with ethylenediaminetetraacetic acid (EDTA) led to an enhancement of activity, similar in concentration dependence as observed before, but without any inhibition of the enzyme at higher concentrations ( Figure 5 ). Of course, such an effect is more evident at low enzyme concentration, i.e. in systems where the Mg 2+ -concentration relative to that of the enzyme is high; thus [Mg] 2+ reduction results in a higher effect. Thus, the different activation/inhibition profiles of the compounds 2-6, displayed e.g. in Figure 3 , result from an overlap of several contrasting effects: a competitive inhibition at the enzyme, the magnesium ion binding properties of inhibitor vs. GPP vs. enzyme, and a resultant irreversible influence on a (concentration dependent) enzymatic activity. In summary, the different substances described show varied effects on ubiA-transferase. For all compounds, a very slightly to significantly increased enzymatic activity was observed at low concentration. This can be attributed to the Mg 2+ -complexating activity inherent to diphosphate mimics. At higher concentrations this positive effect is overruled by the inhibitory activity. The two best inhibitors were the β-oxidized carboxylic acids 2 and 3, the latter is clearly superior. β-Keto acids like 2 may act in their enol form and thus may also be considered as β-hydroxy carboxylates, although with less degree of freedom. These observations guide the way to improved inhibitors in the future. (6E)-7,11-Dimethyl-3-oxododeca-6,10-dienoic acid (2). 28 To a solution of ester 7 (0.5 g, 1.9 mmol) in THF/H 2 O (3:1, 4 mL) was added lithium hydroxide (0.42 g, 9.9 mmol), and the mixture was stirred over night at room temperature, acidified with 1 M hydrochloric acid and then extracted with ether (50 mL). The organic layer was washed with water (2 x 30 mL) and brine (30 mL), dried (Na 2 SO 4 ) and concentrated to give 2 (0.31 g, 66%) as a yellow oil. 1 3 mmol) and 2,4,6-collidine (0.84 mL, 6.5 mmol) in dichloromethane (20 mL) at 0 °C was added TMSBr (0.84 mL, 6.5 mmol) via syringe. After stirring at 0 °C for 30 min, the cooling bath was removed and stirring was continued for 6 h. Then the reaction was quenched by addition of 2 N hydrochloric acid (10 mL). The aqueous phase was extracted with ether (2 x 20 mL) and the organic layers were combined. The organic phase was washed with 2 N hydrochloric acid (2 x 10 mL), water (10 mL) and brine (10 mL), dried (Na 2 SO 4 ) and concentrated to yield 4 (0.54 g, 99%) as a white solid. 1 
Experimental Section
Tripotassium [(4E)-5,9-dimethyldeca-4,8-dienyl]phosphinato](difluoro)methylphosphonate (5).
To a solution of 16 (0.24 g, 0.54 mmol) in dry dichloromethane (3 mL) under argon were added 2,4,6-collidine (0.24 mL, 1.82 mmol) followed by iodotrimethylsilane (0.50 mL, 3.81 mmol) at 0 °C drop-wise over 5 min. The reaction was stirred at 0 °C for 3 h, the solvent was evaporated and the residue was evacuated under vacuum. Aqueous 2 M KOH (2 mL) was added, and the resulting solution was extracted with ether (3 x 5 mL). The aqueous phase was freeze-dried and the organic compound was extracted with methanol (3 x 5 mL). The solvent was evaporated to produce 5 (0.14 g, 78%) as a white, amorphous powder. 1 
Methyl (6E)-7,11-dimethyl-3-oxododeca-6,10-dienoate (7).
A suspension of NaH (0.75g, 60% suspension in mineral oil, 18.7 mmol) in THF (50 mL) was cooled to 0 °C, and a solution of methyl acetoacetate (2 g, 17 mmol) in THF (5 mL) was added dropwise. The mixture was stirred at 0 °C for 1 h. Then n-BuLi (11.7 mL, 1.6 M solution in THF, 18.7 mmol) was added dropwise at -5 °C. The mixture was stirred for 1 h while warming to room temperature and was subsequently cooled to 0 °C. Subsequently, a solution of geranyl bromide (1.84 g, 8.5 mmol) in THF (5 mL) was added dropwise. After stirring the mixture at room temperature for 3.5 h saturated aqueous NH 4 Cl solution (20 mL) was added. The aqueous layer was extracted with ether (3 x 50 mL) and the organic layers were combined. The organic phase was washed with water (40 mL) and brine (40 mL), dried (Na 2 SO 4 ) and concentrated. 
Methyl (6E)-3-hydroxy-7,11-dimethyldodeca-6,10-dienoate (8).
To a solution of compound 7 (0.5 g, 1.9 mmol) in methanol (5 mL) was added sodium borohydride (0.22 g, 5.7 mmol). The mixture was stirred overnight at room temperature, and the reaction was quenched by addition of water (2 mL). The product was extracted with ether (3 x 20 mL), and the combined organic phase was washed with brine (20 mL), dried (Na 2 SO 4 ) and concentrated to give β-hydroxy ester 30 To a solution of dimethyl methylphosphonate (2.4 g, 19.7 mmol) in THF (40 mL) at -78 °C was added dropwise a solution of n-BuLi (12.3 mL, 15% solution in THF, 19.7 mmol). Then, the mixture was stirred at -78 °C for 20 min, and a solution of geranial 9 (3.0 g, 19.7 mmol) in THF (10 mL) was added dropwise at -78 °C. The reaction mixture was stirred for 2 h while warming up. The reaction was quenched by the addition of saturated aqueous ammonium chloride solution. The aqueous phase was extracted with ether (2 x 30 mL), and the combined organic phase was dried (Na 2 SO 4 ) and 
Ethyl (4E)-5,9-dimethyldeca-4,8-dienoate (11).
To a solution of trans-geraniol (5.3 mL, 30 mmol) in ether (25 mL) at -20 °C was added a solution of phosphorus tribromide (1.4 mL, 15 mmol) in ether (15 mL) within 10 min, and the reaction mixture was stirred for 4 h. The reaction was quenched with water, extracted with petroleum ether, washed in turn with water, saturated aqueous NaHCO 3 , and brine. The organic layer was dried (MgSO 4 ) and evaporated at 30 °C to provide (E)-geranyl bromide (6.4 g, 99%) of as a labile yellow liquid. To a suspension of NaH (1.44 g of 60% suspension in mineral oil, 60 mmol) in dry THF (150 mL) under argon was slowly added diethyl malonate (9.14 mL, 60 mmol) at room temperature. The resulting solution was stirred for 30 min, and a solution of geranyl bromide (4.24 g, 19.6 mmol) in THF (10 mL) was added. After stirring for 6 h the reaction mixture was quenched with saturated aqueous ammonium chloride. After addition of ether (300 mL) the organic layer was separated and washed with brine (2 x 100 mL), dried (MgSO 4 ), evaporated, and the bulk of the diethyl malonate removed by Kugelrohr distillation in high vacuum to afford the crude product as residue (7.90 g, max. 19.6 mmol). A mixture of crude diester (7.90 g, max. 19.6 mmol), water (0.45 mL, 25 mmol), and lithium chloride (2.11 g, 50 mmol) in DMSO (40 mL) was heated at reflux for 4 hours. After cooling, the reaction mixture was extracted with ether/petroleum ether (1:1, 300 mL). The extract was washed with water (5 x 50 mL) and brine ( . To a solution of ester 11 (4.00 g, 17.8 mmol) in dry ether (65 mL) at 0 °C was added portionwise LAH (0.68 g, 17.8 mmol), and the mixture was stirred at room temperature for 3 h. After cooling to 0 °C, the reaction was quenched with water (7 mL), followed by NaOH (15%, 7 mL), and the mixture was stirred for 15 min. More water (21 mL) was added, stirring was continued for 30 min and Na 2 SO 4 was added. The mixture was filtered through Celite, the filter cake was extracted with diethyl ether several times, the filtrates were combined, and the solvents were evaporated to give the alcohol (3. Diethyl (4E)-5,9-dimethyldeca-4,8-dienylphosphonate (13) . A mixture of bromide 12 (4.0 g, 16.3 mmol) and triethyl phosphite (54 mL, 326 mmol) was stirred under argon at 150 °C for 20 h. While cooling to room temperature, triethyl phosphite was removed in high vacuum. The crude product was purified by flash chromatography (ethyl acetate/petroleum ether 1:1) to give 13 (4.1 g, 83) as a pale yellow oil. R f = 0.53 (ethyl acetate). 1 (14) . A solution of diester 13 (2.7 g, 9.0 mmol) in methanol (40 mL) was treated with 1 M aqueous potassium hydroxide (40 mL) and heated at 65 °C. The reaction course was monitored by 31 P NMR. After 9 h the pH was adjusted to 6.5, and methanol was evaporated. The aqueous solution was acidified with 10% hydrochloric acid and extracted with ethyl acetate (3 x 50 mL). The organic layer was washed in turn with water and brine, dried (MgSO 4 ), and evaporated to provide the monoacid (2.4 g) as a pale yellow liquid; the purity (>83%, some heat decomposition) was checked by GC-MS. R f = 0.04 (ethyl acetate). 31 P NMR (161.9 MHz, CDCl 3 ): δ 27.6 (s). MS (ESI, negative mode): m/z
To a stirred solution of the monoacid (2.9 g, 10.8 mmol) in dichloromethane (10 mL) was added under argon N,N-dimethyltrimethylsilylamine (1.4 mL, 21.8 mmol). The mixture was stirred at room temperature for 2 h. The solvent was evaporated, the residue was dissolved in benzene (10 mL), and the solvent was evaporated under vacuum for 30 min. The residue was dissolved in dichloromethane (8 mL) containing 4 drops of DMF, and oxalyl chloride (1.5 mL, 18 mmol) was added under argon at 0 °C within 10 min. The solution was stirred at 0 °C for 75 min and then at room temperature for 45 min. After evaporation of the solvent the residue was dissolved in benzene, which in turn, was evaporated under high vacuum to give the unstable acid chloride 14 (3.15 g, 99%) as a labile orange oil that was immediately used without purification for the C-P coupling reaction. (2E,6E)-10-Bromo-11-hydroxy-3,7,11-trimethyldodeca-2,6-dienyl acetate (18). 21 To a stirred solution of E,E-farnesyl acetate 17 (2.1 g, 7.9 mmol) in 1,2-dimethoxyethane (16 mL) and water (10 mL) at 0 °C was added within 30 min a solution of N-bromosuccinimide (1.48 g, 8.3 mmol) in 1,2-dimethoxyethane (25 mL). The mixture was stirred at 0 °C for 4 h and was then poured into brine (40 mL) followed by extraction with ether (3 x 40 mL). The combined organic layer was washed with brine (40 mL), dried (Na 2 SO 4 ) and concentrated in vacuo to give crude 18 (2.82 g) as a pale yellow oil. R f = 0.16 (petroleum ether/ethyl acetate 10:1 (2E,6E)-9-(3,3-Dimethyloxiran-2-yl)-3,7-dimethylnona-2,6-dien-1-ol (19). 21 Bromohydrin 18
(0.35 g, 0.97 mmol) was dissolved in methanol (10 mL), and to the solution was added potassium carbonate (0.40 g, 2.91 mmol). The mixture was stirred over night at room temperature, filtered through Celite, and the filtrate was concentrated in vacuo. The residue was
